Deltex Medical Share Discussion Threads

[mrc2u] 07/7/2022 11:07

Don't we all. But not bothering with news flow is shooting themselves in the foot and us in the walletWhere is the new monitor?This may be my last post for a while as colleagues are pushing me to run for Tory leader. Or at least a couple of guys I play golf withMrC4PM

[chrisdgb] 07/7/2022 07:11

Looking forward to the H2 recovery and hopefully build from there in more normal times........

[mrc2u] 28/6/2022 08:24

Last couple of days of the first half. Would be nice to think there will be a decent piece of news to tide us over to a trading update that reports a return to growthMay be hoping for too much. Still, it's been a decent start to Wimbledon, three great test wins and a Brit won the US Open golf so not all badMrC

[chrisdgb] 23/5/2022 11:37

I remain positive on the story and hope the Board keep us well informed of positive progress........

[schloo] 20/5/2022 15:26

>>gavapentin

I would respond to you point by point but struggling to see what any point you made might actually be

Can't imagine what you imagine The COUNT ought to apologise for either

Hope you have had fun, delighted you are a true expert, sorry I don't know where you work so I can avoid it!

[gavapentin] 20/5/2022 14:10

Too quick to score points - I think that was you!

Please note....editorials do not have a "Discussion" at the end....but then as an expert, you would well know that. Thus there was never any need to reference it ;)

Also you suggest DrEaMing is an outcome not a process....the data actually points to the latter.

There are none so blind as those over invested. As I know to my cost in other stocks.

DEMG is not a bad stock. But even with a major player, it is unlikely to make RAPID reversals of fortune.

I will await the apology from TC with baited breath lmao - too chippy/overinvested to ever recognise others opinions have validity

[schloo] 20/5/2022 13:48

Ah Gavapentin, you got me there! So, turns out there are two DREAM papers in the BJA and you meant the FREE one: shame you were too lazy to give any sort of reference in your original rush to troll but well done for feeling you earned the right to score a cheap shot

Nobody is disagreeing that the evidence is contested: but, back in the day, contesting the evidence did not mean the earth was not round and that it did not orbit the sun

The DREAM concept is simple, elegant and potentially powerful. If a patient is able to drink, eat and move around the day after major surgery they will normally do a lot better than those who cannot. This is not really that novel, is it? If you ring the ward to ask how someone is getting on after an op, it is always good to hear that they have got up and are sitting in a chair having a cup of tea and a biscuit

Of course, those who have studied the ODM evidence base will point out that patients whose fluids were optimised using ODM during surgery are more rather than less likely to be able to drink, eat and move around the day after surgery than those whose fluids were managed using lesser or no technology guidance

If you want to know more about where the DREAM (DRinking EAting Mobilising) concept comes from, try looking at the cartoon on the cheers-dream.com & note that the home page is headed 'Preoperative Fluid Management'. Monty M, the leader of this is also one of the authors of the new PQIP study

The CHEERS acronym is a bit ugly, but C is for carbohydrate loading (not hungry), H is for hydrated (not thirsty) and the first E for euvolemic (the right amount of fluid). So it is all about fluid management and if you do this plus the other E (right amount of salt) you are on track to get a DREAMing patient

The whole point of the DREAM campaign is to get more people using ODM in line with the (uncontestable?) evidence base

My point is that mega company marketing is needed to make this happen because medical science has not been able to do the job. That ought to be sad for everyone and not just those who have lost a lot of money on DEMG backing the evidence and ought to be a source of profound shame to the flat-earthers

[gavapentin] 20/5/2022 08:35

Schloo is no expert. Or he would realise the paper (it is not an editorial) is written by many authors including Ramani M and Mike G who are leaders in this field. And he spend the SMALL amount of money to actually read it!!

He is conflating all sorts in his "expert" piece. You lot are so one-eyed it is embarrassing. Your money betrays your objectivity. I am not pro Edwards or LidCO.
I have no money invested. I am not a troll because I post a piece that doesn't fit with you or TC's narrative of never-ending bullish (basically because you have so much lost money tied up!)

I was stating an opinion in the Discussion of what is arguably the most important paper of the year in the UK anaesthetic literature. Eras-lite or DrEaMing with data from PQIP - I PRESUME YOU DO KNOW ALL ABOUT THAT???!!, is a simple metric that should reduce LoS and possibly complications. Something you keep professing to care so much about....(only when it suits your investment) lol.

It was a comment by the authors. Not me. "Contested"....that is all I said. DYOR! LOL.

[schloo] 18/5/2022 16:45

>>Gavapentin

Seriously? Is that pathetic distortion the best you have got?

1. I'm not going to pay to read an editorial just because of some troll, but the thrust of the piece is obviously supportive of what DEMG have been trying to achieve for years
2. Of course the evidence for goal directed fluid optimisation remains contested. Otherwise it would be enforced as a standard of care across the world
3. There is only one author on this paper, Prof Henrik Kehlet. Spoke to him earlier this year and he categorically does not contest the evidence for goal directed fluid optimisation guided by DEMG's Doppler technologies. He is just very frustrated that so many people can't be bothered with evidence based best practice
4. As highlighted by the Count there are lots of studies with the Edwards & Lidco technologies but they simply can not deliver the same results as DEMG's Doppler. Perhaps that is because they measure completely different things in different ways in different places
5. Conflating PPWA with Doppler has caused confusion, whether due to lack of intellectual rigour or bias or industry affiliation related bias. Fluid optimisation during surgery is highly effective with Doppler but not with PPWA
6. However the choices remain stark: make Doppler happen or carry on wasting lives and money

No idea why you are so anti-DEMG. No idea how you live with yourself for tolerating routine delivery of second rate & harmful care

DEMG have not been able to change your mind, nor has probably the most robust evidence base for any anaesthetic protocol/intervention anywhere ever, nor the myriad of experts who have wasted years trying to lead their colleagues to improve care. This is why DEMG need to sell to a major who can persuade with marketing where medical science has failed

Hope you are still young enough to see the light at a ski 'meeting' or some such activity generously supported with an 'unrestricted educational grant' from DEMG's next owners

[the count] 18/5/2022 15:00

--->BIGT20

I agree with you totally about selling too early. Obviously!

I decided to go to the AGM first thing this morning, so it was a real rush job for me to make the time. The reason I decided first thing this am, is down to the fact that I was expecting to see a notice of AGM announcement first. But apparently it was hidden away deep in the text of the last set of results.

The update looked as if things are slowly turning around, but I repeat, slowly.

The launch of the new monitor should really kick things off, but it is not all quite finished yet. Launch should come later on this year, I will say Q4 just to be conservative.

We took that further lurch downwards recently due to all the shenanigans with Arden, the then house broker, but the company did say today they were very pleased with the new broker.

The new monitor compared to the old one looked like a space rocket compared to a dinosaur.

Also the non invasive supra sternal doppler (forgot what we used to call it years ago.... SupraQ was it? ) could be an extremely useful technology to add to the suite of devices incorporated within the new monitor. But need more time to develop the accuracy although there will be an early version within the new monitor I believe.

I asked if any of the other competitors had even started to develop a comparable evidence base in support of what we have in the operating theatre, and the answer was an emphatic no.

Edwards had just completed one RCT trial in the recent past, but that gave worse results. Yet they still sell millions of dollars of kit based on marketing.

So, as many of us know, there are still idiot clinicians out there buying these products purely based on slick marketing yet with no evidence to back their products.

That is the real scandal here, and has been for many a year, but the idiots who make the buying decisions go on doing so. The hidden damage they must be doing to patients is an absolute travesty, yet governments continue to let these people make, what in some cases must equate to life or death decisions, yet they are unaccountable for their actions.

Anyway, fingers crossed we launch our new monitor soon and the recovery can start, yet again. So many false dawns, but hopefully we are now near the end game even though it is most likely going to fall far short of what we expected many years ago.

Regards,

TC!

[gavapentin] 18/5/2022 14:35

Anyone read the latest BJA about DrEaMing?

"The evidence for processes such as goal-directed fluid optimisation, bowel preparation, and carbohydrate loading remains contested"

Verbatim from Discussion. Senior authors!

Not invested. No wish to invest. Posted FYI

Of course there are studies that show significant benefit but when the great and good conclude the fact above in a very important ERAS-light care bundle paper...it highlights the problems faced.

[chrisdgb] 18/5/2022 14:26

You would think Nigel would be keen to sell at the right price, he has certainly been patient.............!

[bigt20] 18/5/2022 13:56

Now that we have a new monitor, i would like to see the sales build over time before the company is sold. I do not want it sold too early!

[schloo] 18/5/2022 13:15

I did not go to the AGM but thought the update was good news. There are signs of volumes picking up and they have a new monitor pretty much ready to go which incorporates a non-invasive Doppler offer which, in itself, could be a world-beater. As a reminder, the current box was launched in 1999 and has been way too tired to sell many of for years & years. But the market, including the US, is happy to buy more modern newer monitors, even if they do not run anything like as good medical techs as the DEMG ones

They do not have to sell many monitors to double the total sales in H2 over last year and, in my view, ought to be looking to sell to a major strategic company the moment they can point to sales traction. Share price should rise sharply on sales growth and then up again for a control premium

Doing the above is straight out of the LidCo playbook. LidCo ceased the opportunity going into CoVid and DEMG needs to seize it coming out

6p exit ought to be easily doable from here

I agree that there are strong arguments for refreshing the board. Doing so now could easily increase the exit price by a third or a half, so maybe up to 10p. I would much rather get 10p than 6p. But radical change in Board membership just isn't going to happen given the characters involved. That was very clear from putting Cazalet up for a seat yet again, so not sure there is much point in wasting breath calling for change

Will buy some more at least up to 2.5p as & when find some investment cash

[mrc2u] 18/5/2022 12:50

For a newer owner with some marketing resources, skill and power, surely?This needed to be sold ten years ago and would have got ten times what it will now.But I want the exit within the year and think this needs new dynamic Board members and not the cozy nonsense we have at present.MrC

[bigt20] 18/5/2022 12:15

I think so but its going to be a process of building up sales over a few years

[chrisdgb] 18/5/2022 10:43

Please, finally are we are the road to success......??!!

[bigt20] 18/5/2022 10:25

Its just going to take time to build up.

[gbenson1] 18/5/2022 07:01

Hi mrC2u, I've been in DEMG shares for forever, they never seem to be bullish in any of their communicates, which has held the company back. I agree we need a infusion of fresh younger blood on the board which has become stale/set in its ways..

[mrc2u] 18/5/2022 06:39

AGM statement does indicate finally that sales may actually go up, which sounds uncannily like growth. Hip hip hooray!Does not sound very ambitious though. Goals seem to be to get back to pre CoVid levels and also to upgrade some of the installed base over a few years. Dynamism please.MrC

[mrc2u] 17/5/2022 14:34

They are being forced to get new advisers and seem, finally, to be close to having a new box.But no new blood on the Board. The chair has been there since 1989. They want us to re-elect J Cazalet who has been on the Board for 14 years and, like the chair will be 75 this year.What new ideas are they going to ever bring now?MrC

[mrc2u] 17/5/2022 14:25

Just read small print and see the DEMG AGM is tomorrow morning. Proper companies announce the date separately. I know that because I am going to a proper company's AGM tomorrow morning...Anyone clock this and actually able to go?MrC

[maxk] 04/5/2022 14:24

Cool beans..



The Board has concluded that it is now appropriate to raise a total of approximately GBP1.4 million by way of subscription for 111,720,000 Subscription Shares at a price of 1.25 pence per Deltex Medical ordinary share ("Share"). This represents a 9% discount to the closing mid-market Share price on 07 February 2022.

Certain directors of the Company, namely Nigel Keen, Julian Cazalet, Mark Wippell, Natalie Wettler and Andy Mears, intend to participate in the Subscription for, in aggregate, 32,610,400 new Shares at the Issue Price.